Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

494.50p
   
  • Change Today:
      55.00p
  • 52 Week High: 497.08
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.20m
  • Volume: 566,990
  • Market Cap: £525.16m
  • RiskGrade: 125
  • Beta: 0.02

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
78.80% above the market average78.80% above the market average78.80% above the market average78.80% above the market average78.80% above the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
19.12% above the market average19.12% above the market average19.12% above the market average19.12% above the market average19.12% above the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Price Book Ratio
88.97% below the market average88.97% below the market average88.97% below the market average88.97% below the market average88.97% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average
82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average
Price Chg 3m
92.57% above the market average92.57% above the market average92.57% above the market average92.57% above the market average92.57% above the market average
82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
95.42% above the market average95.42% above the market average95.42% above the market average95.42% above the market average95.42% above the market average
90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average
Momentum 20
95.57% above the market average95.57% above the market average95.57% above the market average95.57% above the market average95.57% above the market average
90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
64.82% below the market average64.82% below the market average64.82% below the market average64.82% below the market average64.82% below the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
96.37% below the market average96.37% below the market average96.37% below the market average96.37% below the market average96.37% below the market average
95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
27.77% above the market average27.77% above the market average27.77% above the market average27.77% above the market average27.77% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average
Operating Profit Loss
94.32% below the market average94.32% below the market average94.32% below the market average94.32% below the market average94.32% below the market average
95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
46.77% above the market average46.77% above the market average46.77% above the market average46.77% above the market average46.77% above the market average
65.00% above the sector average65.00% above the sector average65.00% above the sector average65.00% above the sector average65.00% above the sector average
Cash
57.39% above the market average57.39% above the market average57.39% above the market average57.39% above the market average57.39% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
53.79% above the market average53.79% above the market average53.79% above the market average53.79% above the market average53.79% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
43.46% below the market average43.46% below the market average43.46% below the market average43.46% below the market average43.46% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Brokers Percent Neutral
24.85% above the market average24.85% above the market average24.85% above the market average24.85% above the market average24.85% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 494.50p
Change Today 55.00p
% Change 12.51 %
52 Week High 497.08
52 Week Low 232.50
Volume 566,990
Shares Issued 106.20m
Market Cap £525.16m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.05% below the market average34.05% below the market average34.05% below the market average34.05% below the market average34.05% below the market average
16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average
Price Trend
81.31% above the market average81.31% above the market average81.31% above the market average81.31% above the market average81.31% above the market average
82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average
Income Not Available
Growth
5.06% above the market average5.06% above the market average5.06% above the market average5.06% above the market average5.06% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-Aug-2025

Time Volume / Share Price
16:22 160 @ 493.50p
16:35 84,858 @ 494.50p
16:35 168 @ 494.50p
16:35 1,894 @ 494.50p
16:35 270 @ 494.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page